LAS VEGAS —Finding treatment options for glaucoma beyond IOP lowering may be the future course toward preventing blindness in glaucoma, according to a speaker here.
“Remember that visual loss in glaucoma arises from damage to the retinal ganglion cell interfering with transmission of visual information to the brain,” Richard A. Lewis, MD, said during the Binkhorst Lecture at the American Society of Cataract and Refractive Surgery meeting. “Very simply, and if we can impact this pathway, we can treat the disease in very, very different ways.”
Neuroprotection has